• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症——全科医疗中的预防与检测

Osteoporosis - prevention and detection in general practice.

作者信息

Ewald Dan

机构信息

Northern Rivers General Practice Network and a general practitioner, New South Wales.

出版信息

Aust Fam Physician. 2012 Mar;41(3):104-8.

PMID:22396922
Abstract

BACKGROUND

Osteoporosis causes a large and growing health burden in Australia. Effective treatments are available, but these are inconsistently implemented. There is some inconsistency in expert advice on who should be recommended to have bone densitometry.

OBJECTIVE

This review draws on the available high level evidence for what works in prevention and discusses the rationale for using absolute risk estimations for decision making.

DISCUSSION

Effective interventions for the prevention and early intervention of osteoporosis have not been delivered as widely as they should be. Efforts should be focused on offering treatment to those groups with the highest risk of fracture, particularly those that have had a fragility fracture. There is synergy in the lifestyle recommendations for bone health with other aspects of health, so these should be addressed as thoroughly as possible.

摘要

背景

骨质疏松症给澳大利亚带来了巨大且不断增加的健康负担。虽然有有效的治疗方法,但这些方法的实施并不一致。关于应推荐哪些人进行骨密度测量的专家建议也存在一些不一致之处。

目的

本综述借鉴了关于有效预防措施的现有高级证据,并讨论了使用绝对风险估计进行决策的基本原理。

讨论

骨质疏松症预防和早期干预的有效干预措施并未得到应有的广泛应用。应努力为骨折风险最高的人群提供治疗,特别是那些发生过脆性骨折的人群。关于骨骼健康的生活方式建议与健康的其他方面具有协同作用,因此应尽可能全面地加以解决。

相似文献

1
Osteoporosis - prevention and detection in general practice.骨质疏松症——全科医疗中的预防与检测
Aust Fam Physician. 2012 Mar;41(3):104-8.
2
Osteoporosis risk in premenopausal women.绝经前女性的骨质疏松风险
Pharmacotherapy. 2009 Mar;29(3):305-17. doi: 10.1592/phco.29.3.305.
3
Osteoporosis - pharmacological prevention and management in older people.骨质疏松症——老年人的药物预防与管理
Aust Fam Physician. 2012 Mar;41(3):110-8.
4
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.绝经后妇女骨质疏松症的管理:北美绝经学会 2010 年立场声明。
Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.
5
The pathogenesis, diagnosis, investigation and management of osteoporosis.骨质疏松症的发病机制、诊断、研究和管理。
J Clin Pathol. 2011 Dec;64(12):1042-50. doi: 10.1136/jcp.2010.077842. Epub 2011 Sep 6.
6
Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.老年女性骨质疏松症抗吸收药物使用的趋势及决定因素
Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95. doi: 10.1002/pds.1068.
7
Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.评估骨折风险及骨质疏松症药物的作用:骨密度及其他方面
Am J Med. 2009 Nov;122(11):992-7. doi: 10.1016/j.amjmed.2009.05.018.
8
Prevention, screening, and management of osteoporosis: an overview of the current strategies.骨质疏松症的预防、筛查与管理:当前策略概述
Postgrad Med. 2009 Jul;121(4):5-17. doi: 10.3810/pgm.2009.07.2021.
9
Prevention of osteoporosis and fractures.骨质疏松症与骨折的预防。
Am Fam Physician. 1999 Jul;60(1):194-202.
10
Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.糖皮质激素性骨质疏松症:病理生理学与治疗选择综述
Minerva Med. 2008 Feb;99(1):23-43.

引用本文的文献

1
Improving osteoporosis management in general practice: a pharmacist-led drug use evaluation program.改善全科医疗中的骨质疏松症管理:一项由药剂师主导的药物使用评估项目。
Drugs Aging. 2014 Sep;31(9):703-9. doi: 10.1007/s40266-014-0194-0.